Plain-English translation of NCT07795528 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is testing whether simple blood tests can detect tiny amounts of cancer DNA left behind after colon cancer surgery. The study will follow 392 patients with early-stage colon cancer who have specific genetic changes in their tumors, drawing blood regularly over time to see if these blood tests can predict cancer recurrence months before imaging scans would show it.
Even after successful surgery to remove colon cancer, 20–40% of patients experience recurrence. Current staging systems and imaging cannot reliably predict who will relapse or detect recurrence early enough. This study aims to fill that gap by using advanced blood tests to catch residual disease before it becomes dangerous.
You likely qualify if…
You likely don't qualify if…
As a participant, you would receive your standard cancer follow-up care and imaging tests as usual. In addition, you would have blood drawn at scheduled visits over time—these blood samples are tested for cancer DNA markers to see if they predict recurrence before your imaging shows anything. The study is purely observational, meaning no experimental drugs or treatments are given; you simply donate blood samples and undergo routine monitoring.
AI-generated summary from trial data · Sep 4, 2026 · Not medical advice
China